Search all trials

Find therapies in clinical trials near you – page 29

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of venetoclax and azacitidine treatment in adults with NPM1-mutated acute myeloid leukemia who experience molecular relapse or disease progression

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study Comparing Pirtobrutinib with Idelalisib and Rituximab or Bendamustine and Rituximab for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Idelalisib

Contact Research Centre

Diffuse large B-cell lymphoma refractory

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Polatuzumab Vedotin with Rituximab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Oxaliplatin

Contact Research Centre

Acute lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Blinatumomab

Contact Research Centre

Acute myeloid leukaemia (in remission)

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Decitabine and Venetoclax for Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Decitabine

Contact Research Centre

Anaemia+1

Not recruiting

InvestigationalNo placebo

Study of SEL120 Monohydrochloride for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride

Contact Research Centre

Chronic myeloid leukaemia

Not recruiting

Registered drugNo placebo

Comparison of Nilotinib versus Imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Imatinib

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan

Contact Research Centre

Breast cancer

Not recruiting

Registered drug

Study on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Warm autoimmune haemolytic anaemia

Not recruiting

Registered drug

Study of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Danazol

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Find therapies in clinical trials near you – page 29

392 trials match your criteria

Acute myeloid leukaemia

Study of venetoclax and azacitidine treatment in adults with NPM1-mutated acute myeloid leukemia who experience molecular relapse or disease progression

Chronic lymphocytic leukaemia

Study Comparing Pirtobrutinib with Idelalisib and Rituximab or Bendamustine and Rituximab for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Diffuse large B-cell lymphoma refractory

Study on the Safety and Effectiveness of Polatuzumab Vedotin with Rituximab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Acute lymphocytic leukaemia

Study on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination

Acute myeloid leukaemia (in remission)

Study on the Effectiveness of Decitabine and Venetoclax for Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy

Anaemia+1

Study of SEL120 Monohydrochloride for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)

Chronic myeloid leukaemia

Comparison of Nilotinib versus Imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission

HER2 positive breast cancer

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Breast cancer

Study on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation

Non-small cell lung cancer

Study Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Warm autoimmune haemolytic anaemia

Study of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment

Bladder cancer

Study on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.